Stage IV ovarian germ cell tumor
Showing 1 - 25 of >10,000
HER2-positive Breast Cancer, Stage III Ovarian Epithelial Cancer, Stage III Ovarian Germ Cell Tumor Trial in Seattle
Active, not recruiting
- HER2-positive Breast Cancer
- +8 more
- pNGVL3-hICD vaccine
- +6 more
-
Seattle, WashingtonFred Hutchinson Cancer Research Center/University of Washington
Nov 1, 2022
Male Breast Cancer, Recurrent Melanoma, Stage IV Breast Cancer Trial in Columbus (propranolol HCl, Correlative Studies)
Completed
- Male Breast Cancer
- +7 more
- propranolol hydrochloride
- Correlative Studies
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Dec 4, 2022
Brenner Tumor, Malignant Ascites, Malignant Pleural Effusion Trial in United States (metformin HCl, , Chemotherapy)
Suspended
- Brenner Tumor
- +27 more
- metformin hydrochloride
- +2 more
-
Birmingham, Alabama
- +9 more
May 16, 2022
Stage III Ovarian Epithelial Cancer, Stage III Ovarian Germ Cell Tumor, Stage IV Ovarian Epithelial Cancer Trial in Seattle
Completed
- Stage III Ovarian Epithelial Cancer
- +3 more
- pUMVC3-hIGFBP-2 multi-epitope plasmid DNA vaccine
- laboratory biomarker analysis
-
Seattle, WashingtonFred Hutchinson Cancer Research Center/University of Washington
Feb 22, 2021
Adult Solid Tumor, Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum Trial in Philadelphia (PD-0332991)
Completed
- Adult Solid Tumor
- +38 more
-
Philadelphia, PennsylvaniaAbramson Cancer Center of The University of Pennsylvania
Feb 18, 2021
Advanced Colorectal Carcinoma, Advanced Lung Non-Small Cell Carcinoma, Advanced Malignant Solid Tumor Trial in Sacramento
Recruiting
- Advanced Colorectal Carcinoma
- +15 more
- Fermented Wheat Germ Extract
-
Sacramento, CaliforniaUniversity of California Davis Comprehensive Cancer Center
Jul 26, 2023
Testicular Germ Cell Tumor Trial in Saint-Petersburg (Orchofuniculectomy with simultaneous laparoscopic biopsy of the sentinel
Recruiting
- Testicular Germ Cell Tumor
- Orchofuniculectomy with simultaneous laparoscopic biopsy of the sentinel lymph node using indocyanine green dye with/without methylene blue dye.
- Radiopharmaceutical administration (Technetium/methylene blue)
-
Saint-Petersburg, Russian FederationFederal State Budgetary Institute N.N. Petrov National Medical R
Nov 10, 2023
Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Tumor, Fallopian Tube Mucinous Tumor Trial in Rochester
Active, not recruiting
- Fallopian Tube Clear Cell Adenocarcinoma
- +22 more
- Laboratory Biomarker Analysis
- Multi-epitope Folate Receptor Alpha-loaded Dendritic Cell Vaccine
-
Rochester, MinnesotaMayo Clinic
Oct 7, 2022
Germ Cell Tumor, Seminoma, Non-seminomatous Germ Cell Tumor Trial in Indianapolis (Cabozantinib)
Recruiting
- Germ Cell Tumor
- +3 more
-
Indianapolis, IndianaIndiana University Melvin & Bren Simon Cancer Center
Nov 16, 2022
Germ Cell Tumor, Non-seminomatous Germ Cell Tumor, Ovarian Germ Cell Tumor Trial in Indianapolis (Etoposide)
Recruiting
- Germ Cell Tumor
- +2 more
-
Indianapolis, IndianaIndiana University Melvin & Bren Simon Cancer Center
Dec 20, 2022
Stage I Testicular Seminoma, Stage I Testicular Nonseminomatous Germ Cell Tumor, Gastrointestinal Stromal Tumors Trial in
Not yet recruiting
- Stage I Testicular Seminoma
- +13 more
- Oncological Follow-up
-
Amiens, France
- +2 more
Aug 12, 2022
NSCLC (NSCLC) Trial in Shanghai (Tumor treating fields(EFE-P100), Docetaxel injection)
Not yet recruiting
- Non-small Cell Lung Cancer (NSCLC)
- Tumor treating fields(EFE-P100)
- Docetaxel injection
-
Shanghai, ChinaShanghai Pulmonary Hospital
Dec 21, 2022
Stage III Malignant Melanoma of Skin AJCC V6, Stage IV Malignant Melanoma of Skin Trial in Santiago (TAPCells vaccine)
Completed
- Stage III Malignant Melanoma of Skin AJCC V6
- Stage IV Malignant Melanoma of Skin
- TAPCells vaccine
-
Santiago, RM, ChileFaculty of Medicine, University of Chile
Nov 21, 2023
Cervical Adenocarcinoma, Cervical Adenosarcoma, Cervical Adenosquamous Carcinoma Trial in United States (biological, other,
Recruiting
- Cervical Adenocarcinoma
- +47 more
- Bevacizumab
- +3 more
-
Phoenix, Arizona
- +3 more
Dec 5, 2022
Stage II Fallopian Tube Cancer AJCC v8, Stage II Ovarian Cancer AJCC v8, Stage II Primary Peritoneal Cancer AJCC v8 Trial in
Not yet recruiting
- Stage II Fallopian Tube Cancer AJCC v8
- +33 more
- Alpha-type-1 Polarized Dendritic Cells
- Autologous Natural Killer Cell-like CTLs
-
Buffalo, New YorkRoswell Park Cancer Institute
Apr 1, 2022
Melanoma Neuroendocrine Tumors Neuroectodermal Tumors Tumors Germ Cell and Embryonal Tumors by Histologic Type Tumors Tumors
Not yet recruiting
- Melanoma Neuroendocrine Tumors Neuroectodermal Tumors Neoplasms Germ Cell and Embryonal Neoplasms by Histologic Type Neoplasms Neoplasms
- HX008 + TACE
- +2 more
-
Beijing, Beijing, ChinaBeijing Cancer hospital
Dec 8, 2022
Childhood Extracranial Germ Cell Tumor, Extragonadal Embryonal Carcinoma, Germ Cell Tumor Trial in Worldwide (other, biological,
Recruiting
- Childhood Extracranial Germ Cell Tumor
- +30 more
- Best Practice
- +12 more
-
Birmingham, Alabama
- +579 more
Jan 30, 2023
Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Colorectal Carcinoma, Metastatic Malignant Solid Tumor Trial in Canada,
Active, not recruiting
- Clinical Stage IV Cutaneous Melanoma AJCC v8
- +20 more
- Pembrolizumab
- Ziv-Aflibercept
-
Tampa, Florida
- +8 more
Jan 3, 2023
Ovarian Cancer Trial in United States (Vigil™)
Active, not recruiting
- Ovarian Cancer
- Vigil™
-
West Palm Beach, Florida
- +5 more
Feb 9, 2022
Childhood Embryonal Tumor, Childhood Extracranial Germ Cell Tumor, Childhood Extragonadal Germ Cell Tumor Trial in Worldwide
Completed
- Childhood Embryonal Tumor
- +17 more
- conventional surgery
- +4 more
-
Birmingham, Alabama
- +125 more
Jul 9, 2021
Advanced Breast Carcinoma, Advanced Endometrial Carcinoma, Advanced Fallopian Tube Carcinoma Trial in Houston (biological, drug,
Recruiting
- Advanced Breast Carcinoma
- +73 more
- Atezolizumab
- +3 more
-
Houston, TexasM D Anderson Cancer Center
May 5, 2022
Stage III Ovarian Cancer, Stage IV Ovarian Cancer Trial in Dallas (Vigil™ Vaccine, Bevacizumab)
Completed
- Stage III Ovarian Cancer
- Stage IV Ovarian Cancer
- Vigil™ Vaccine
- Bevacizumab
-
Dallas, TexasMary Crowley Cancer Research Centers
Oct 15, 2021
Unresectable Melanoma, Metastatic Melanoma, Stage III NSCLC Trial in Louisville, New York (IOV-4001)
Recruiting
- Unresectable Melanoma
- +3 more
- IOV-4001
-
Louisville, Kentucky
- +2 more
Nov 21, 2022